Olivier Danos Joins Biogen Idec, Inc. (Massachusetts) As Senior Vice President, Gene Therapy
Biogen Idec (NASDAQ:BIIB) today announced that Olivier Danos, Ph.D., has joined the company as senior vice president, Gene Therapy. Dr. Danos reports directly to Douglas Williams, Ph.D., executive vice president, Research and Development, and is a member of Biogen Idec’s Senior Research and Development Leadership Team.
Help employers find you! Check out all the jobs and post your resume.